ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Price & Overview
NASDAQ:ASBP • US7389202067
Current stock price
The current stock price of ASBP is 0.213 USD. Today ASBP is up by 8.23%. In the past month the price decreased by -77.36%. In the past year, price decreased by -98.99%.
ASBP Key Statistics
- Market Cap
- 1.069M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -65.94
- Dividend Yield
- N/A
ASBP Stock Performance
ASBP Stock Chart
ASBP Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ASBP. When comparing the yearly performance of all stocks, ASBP is a bad performer in the overall market: 99.74% of all stocks are doing better.
ASBP Earnings
ASBP Forecast & Estimates
ASBP Groups
Sector & Classification
ASBP Financial Highlights
Over the last trailing twelve months ASBP reported a non-GAAP Earnings per Share(EPS) of -65.94. The EPS decreased by -282.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1194.47% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ASBP Ownership
ASBP Latest News, Press Relases and Analysis
ASBP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.28 | 853.191B | ||
| JNJ | JOHNSON & JOHNSON | 17.7 | 544.731B | ||
| MRK | MERCK & CO. INC. | 22.09 | 278.01B | ||
| PFE | PFIZER INC | 8.96 | 155.349B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.31 | 121.259B | ||
| ZTS | ZOETIS INC | 16.67 | 49.697B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.61 | 28.547B | ||
| VTRS | VIATRIS INC | 5.85 | 17.152B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.39 | 11.291B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.359B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.199B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.101B | ||
| CORT | CORCEPT THERAPEUTICS INC | 84.68 | 4.797B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ASBP
Company Profile
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
Company Info
IPO: 2022-02-18
ASPIRE BIOPHARMA HOLDINGS IN
194 Candelaro Drive, #233
Humacao NEW YORK PR
Employees: 0
Phone: 15617048527
ASPIRE BIOPHARMA HOLDINGS IN / ASBP FAQ
What does ASBP do?
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
Can you provide the latest stock price for ASPIRE BIOPHARMA HOLDINGS IN?
The current stock price of ASBP is 0.213 USD. The price increased by 8.23% in the last trading session.
Does ASPIRE BIOPHARMA HOLDINGS IN pay dividends?
ASBP does not pay a dividend.
What is the ChartMill technical and fundamental rating of ASBP stock?
ASBP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Would investing in ASPIRE BIOPHARMA HOLDINGS IN be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ASBP.